Direava Selected for Phase 4 of METI and NEDO's Domestic Generative AI Development Project 'GENIAC' — Advancing Development and Demonstration of a 'Future Prediction Model for Surgical Procedures' to Enhance Surgical Safety

Direava Inc. (Headquarters: Chiyoda-ku, Tokyo; CEO: Yuji Takeuchi; hereinafter 'Direava') announces its selection for Phase 4 of the 'Post-5G Information and Communication Systems Infrastructure Strengthening Research and Development Program / Development of Competitive Generative AI Foundation Models (GENIAC)' promoted by the Ministry of Economy, Trade and Industry (METI) and NEDO (New Energy and Industrial Technology Development Organization).

The selected R&D theme is 'Development and Demonstration of a "Future Prediction Model for Surgical Procedures" to Enhance Surgical Safety.' Through this project, Direava will accelerate research and development of next-generation generative AI foundation technologies aimed at drastically reducing complications and improving medical safety.

■ About the Selected Project

Under this project, Direava will work on building a 'Future Prediction Model for Surgical Procedures' to enhance surgical safety.

Leveraging its accumulated technical expertise, the company will advance the development of foundation models that utilize diverse data modalities related to surgery, such as 'images' and 'language.' Through this model, Direava aims to support high-level decision-making in complex surgical procedures and achieve the societal implementation of safe medical practices independent of surgeons' experience levels.

Additionally, the development know-how and outcomes obtained through this project will be widely shared and disseminated, to the extent possible, to contribute to the further development of Japan's domestic generative AI ecosystem.

■ About GENIAC

GENIAC (Generative AI Accelerator Challenge) is a national project jointly promoted by METI and NEDO to strengthen Japan's foundational technologies in generative AI.

By supporting critical elements such as computational resource acquisition, dataset accumulation, and knowledge sharing necessary for developing foundation models—the key to enhancing generative AI development capabilities—GENIAC aims to boost sustainable generative AI innovation and accelerate its societal implementation. Direava's project, 'Development and Demonstration of a "Future Prediction Model for Surgical Procedures" to Enhance Surgical Safety,' has been newly selected under this initiative.

■ About Direava

Direava is a startup founded by active practicing surgeons, dedicated to reducing intraoperative complications through AI technologies developed from a 'surgeon's perspective.' Through this R&D initiative, Direava will further accelerate the societal implementation of 'AI × Surgery' and contribute to improving the safety and quality of all surgical procedures.

【We Are Seeking Passionate Team Members】

Direava is actively recruiting new talent.

Our mission is 'Bringing Intelligence to Surgery, Innovation to the Surgical Field.' We are developing an intelligent platform that integrates anatomical recognition, intraoperative support, and postoperative analysis to address global challenges such as surgeon shortages and skill disparities. We are looking for individuals who share our vision and are ready to help shape the future of healthcare.

We are a cross-functional team that collaborates across technology, clinical expertise, and business to directly address real-world challenges and deliver truly valuable technologies for both physicians and patients.

We welcome individuals who can persistently tackle difficult challenges and see them through to completion with full responsibility.

We welcome those who want to actively engage in technologies that transform medical practice.

We sincerely look forward to welcoming you.

Open Positions: Sales, Engineers

Contact: info@direava.com